0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemoperfusion Market Research Report 2026
Published Date: 2026-01-08
|
Report Code: QYRE-Auto-21H5212
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Hemoperfusion Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Hemoperfusion Market Research Report 2026

Code: QYRE-Auto-21H5212
Report
2026-01-08
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemoperfusion Market Size

The global Hemoperfusion market was valued at US$ 478 million in 2025 and is anticipated to reach US$ 814 million by 2032, at a CAGR of 8.6% from 2026 to 2032.

Hemoperfusion Market

Hemoperfusion Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemoperfusion competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.In 2025, global Hemoperfusion production reached approximately 7052 K Unit.
Hemoperfusion demand is driven first by clinical need in critical care where standard supportive therapies (ventilation, vasopressors, renal replacement therapy) don’t directly remove circulating toxins or inflammatory mediators. The core use-cases that pull adoption are: acute poisonings/drug intoxications (where removing protein-bound or lipophilic toxins can matter), liver failure and hyperbilirubinemia, and severe systemic inflammation (sepsis/septic shock, pancreatitis, certain post-surgical or trauma inflammatory states) where clinicians aim to reduce circulating cytokines/endotoxin burden. Growth is also supported by rising ICU volumes tied to aging populations and higher prevalence of multi-morbidity (cardiometabolic disease, chronic kidney disease), plus increasing recognition of “adjunctive blood purification” options in settings where mortality remains high despite best-practice bundles.
A second set of drivers is workflow and technology fit: hemoperfusion can be deployed as a stand-alone circuit or integrated with CRRT/ECMO platforms, allowing hospitals to add it without building an entirely new infrastructure. The market is pulled by single-use consumables (cartridges/columns) with predictable ordering patterns once protocols are established, and by product improvements such as higher adsorption capacity, better biocompatibility, lower clotting risk, and more consistent performance across patient conditions. Commercial adoption is strongly influenced by reimbursement coverage, local health-technology assessments, and hospital procurement economics (ICU length-of-stay impact, vasopressor days, dialysis days). Finally, evidence quality is a major gatekeeper: more positive real-world data, better patient-selection criteria, and clearer endpoints (hemodynamic stabilization, organ-support intensity, biomarker kinetics) tend to unlock broader uptake, while mixed trial outcomes can slow it or confine usage to specific indications and regions.
Gross profit margin (industry, short): hemoperfusion is typically a high–gross-margin consumables model (single-use cartridges plus accessories) once scale and yields are stable, because material costs are modest relative to clinical selling price and value is tied to outcomes and compatibility. In practice, margins vary widely by region and competitive intensity, but many established players target roughly ~50–70% gross margin.
This report delivers a comprehensive overview of the global Hemoperfusion market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemoperfusion. The Hemoperfusion market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemoperfusion market comprehensively. Regional market sizes by Type, by Application, by Feature, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemoperfusion manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hemoperfusion Market Report

Report Metric Details
Report Name Hemoperfusion Market
Accounted market size in 2025 US$ 478 million
Forecasted market size in 2032 US$ 814 million
CAGR 8.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Activated Carbon Adsorption
  • Resin Adsorption
Segment by Feature
  • Plasma Perfusion
  • Whole Blood Perfusion
Segment by Channel
  • Direct Selling
  • Distribution
by Application
  • Hepatic Encephalopathy
  • Certain Autoimmune Diseases
  • Drug Overdose
  • Specific Intoxications
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jianfan Biotech, Kangbei Medical, Foshan Boxin (Lily Medical), Baxter, Asahi Kasei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Feature, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hemoperfusion manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hemoperfusion sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hemoperfusion Market growing?

Ans: The Hemoperfusion Market witnessing a CAGR of 8.6% during the forecast period 2026-2032.

What is the Hemoperfusion Market size in 2032?

Ans: The Hemoperfusion Market size in 2032 will be US$ 814 million.

Who are the main players in the Hemoperfusion Market report?

Ans: The main players in the Hemoperfusion Market are Jianfan Biotech, Kangbei Medical, Foshan Boxin (Lily Medical), Baxter, Asahi Kasei

What are the Application segmentation covered in the Hemoperfusion Market report?

Ans: The Applications covered in the Hemoperfusion Market report are Hepatic Encephalopathy, Certain Autoimmune Diseases, Drug Overdose, Specific Intoxications, Others

What are the Type segmentation covered in the Hemoperfusion Market report?

Ans: The Types covered in the Hemoperfusion Market report are Activated Carbon Adsorption, Resin Adsorption

1 Hemoperfusion Market Overview
1.1 Product Definition
1.2 Hemoperfusion by Type
1.2.1 Global Hemoperfusion Market Value by Type: 2025 vs 2032
1.2.2 Activated Carbon Adsorption
1.2.3 Resin Adsorption
1.3 Hemoperfusion by Feature
1.3.1 Global Hemoperfusion Market Value by Feature: 2025 vs 2032
1.3.2 Plasma Perfusion
1.3.3 Whole Blood Perfusion
1.4 Hemoperfusion by Channel
1.4.1 Global Hemoperfusion Market Value by Channel: 2025 vs 2032
1.4.2 Direct Selling
1.4.3 Distribution
1.5 Hemoperfusion by Application
1.5.1 Global Hemoperfusion Market Value by Application: 2025 vs 2032
1.5.2 Hepatic Encephalopathy
1.5.3 Certain Autoimmune Diseases
1.5.4 Drug Overdose
1.5.5 Specific Intoxications
1.5.6 Others
1.6 Global Hemoperfusion Market Size Estimates and Forecasts
1.6.1 Global Hemoperfusion Revenue 2021–2032
1.6.2 Global Hemoperfusion Sales 2021–2032
1.6.3 Global Hemoperfusion Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Hemoperfusion Market Competition by Manufacturers
2.1 Global Hemoperfusion Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemoperfusion Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemoperfusion Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemoperfusion, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemoperfusion, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemoperfusion, Product Types and Applications
2.7 Global Key Manufacturers of Hemoperfusion, Date of Entry into the Industry
2.8 Global Hemoperfusion Market Competitive Situation and Trends
2.8.1 Global Hemoperfusion Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemoperfusion Players Market Share by Revenue
2.8.3 Global Hemoperfusion Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemoperfusion Market Scenario by Region
3.1 Global Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemoperfusion Sales by Region: 2021–2032
3.2.1 Global Hemoperfusion Sales by Region: 2021–2026
3.2.2 Global Hemoperfusion Sales by Region: 2027–2032
3.3 Global Hemoperfusion Revenue by Region: 2021–2032
3.3.1 Global Hemoperfusion Revenue by Region: 2021–2026
3.3.2 Global Hemoperfusion Revenue by Region: 2027–2032
3.4 North America Hemoperfusion Market Facts & Figures by Country
3.4.1 North America Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemoperfusion Sales by Country (2021–2032)
3.4.3 North America Hemoperfusion Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemoperfusion Market Facts & Figures by Country
3.5.1 Europe Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemoperfusion Sales by Country (2021–2032)
3.5.3 Europe Hemoperfusion Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemoperfusion Market Facts & Figures by Region
3.6.1 Asia Pacific Hemoperfusion Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemoperfusion Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemoperfusion Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemoperfusion Market Facts & Figures by Country
3.7.1 Latin America Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemoperfusion Sales by Country (2021–2032)
3.7.3 Latin America Hemoperfusion Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemoperfusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemoperfusion Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemoperfusion Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemoperfusion Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemoperfusion Sales by Type (2021–2032)
4.1.1 Global Hemoperfusion Sales by Type (2021–2026)
4.1.2 Global Hemoperfusion Sales by Type (2027–2032)
4.1.3 Global Hemoperfusion Sales Market Share by Type (2021–2032)
4.2 Global Hemoperfusion Revenue by Type (2021–2032)
4.2.1 Global Hemoperfusion Revenue by Type (2021–2026)
4.2.2 Global Hemoperfusion Revenue by Type (2027–2032)
4.2.3 Global Hemoperfusion Revenue Market Share by Type (2021–2032)
4.3 Global Hemoperfusion Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemoperfusion Sales by Application (2021–2032)
5.1.1 Global Hemoperfusion Sales by Application (2021–2026)
5.1.2 Global Hemoperfusion Sales by Application (2027–2032)
5.1.3 Global Hemoperfusion Sales Market Share by Application (2021–2032)
5.2 Global Hemoperfusion Revenue by Application (2021–2032)
5.2.1 Global Hemoperfusion Revenue by Application (2021–2026)
5.2.2 Global Hemoperfusion Revenue by Application (2027–2032)
5.2.3 Global Hemoperfusion Revenue Market Share by Application (2021–2032)
5.3 Global Hemoperfusion Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jianfan Biotech
6.1.1 Jianfan Biotech Company Information
6.1.2 Jianfan Biotech Description and Business Overview
6.1.3 Jianfan Biotech Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jianfan Biotech Hemoperfusion Product Portfolio
6.1.5 Jianfan Biotech Recent Developments/Updates
6.2 Kangbei Medical
6.2.1 Kangbei Medical Company Information
6.2.2 Kangbei Medical Description and Business Overview
6.2.3 Kangbei Medical Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Kangbei Medical Hemoperfusion Product Portfolio
6.2.5 Kangbei Medical Recent Developments/Updates
6.3 Foshan Boxin (Lily Medical)
6.3.1 Foshan Boxin (Lily Medical) Company Information
6.3.2 Foshan Boxin (Lily Medical) Description and Business Overview
6.3.3 Foshan Boxin (Lily Medical) Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Foshan Boxin (Lily Medical) Hemoperfusion Product Portfolio
6.3.5 Foshan Boxin (Lily Medical) Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Hemoperfusion Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Asahi Kasei
6.5.1 Asahi Kasei Company Information
6.5.2 Asahi Kasei Description and Business Overview
6.5.3 Asahi Kasei Hemoperfusion Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Asahi Kasei Hemoperfusion Product Portfolio
6.5.5 Asahi Kasei Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemoperfusion Industry Chain Analysis
7.2 Hemoperfusion Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemoperfusion Production Mode & Process Analysis
7.4 Hemoperfusion Sales and Marketing
7.4.1 Hemoperfusion Sales Channels
7.4.2 Hemoperfusion Distributors
7.5 Hemoperfusion Customer Analysis
8 Hemoperfusion Market Dynamics
8.1 Hemoperfusion Industry Trends
8.2 Hemoperfusion Market Drivers
8.3 Hemoperfusion Market Challenges
8.4 Hemoperfusion Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemoperfusion Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hemoperfusion Market Value by Feature (US$ Million), 2025 vs 2032
 Table 3. Global Hemoperfusion Market Value by Channel (US$ Million), 2025 vs 2032
 Table 4. Global Hemoperfusion Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Hemoperfusion Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Hemoperfusion Sales (K Units) of Key Manufacturers (2021–2026)
 Table 7. Global Hemoperfusion Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Hemoperfusion Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Hemoperfusion Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Hemoperfusion Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Hemoperfusion, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Hemoperfusion, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Hemoperfusion, Product Types and Applications
 Table 14. Global Key Manufacturers of Hemoperfusion, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Hemoperfusion Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemoperfusion Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Hemoperfusion Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Hemoperfusion Sales by Region (K Units), 2021–2026
 Table 20. Global Hemoperfusion Sales Market Share by Region (2021–2026)
 Table 21. Global Hemoperfusion Sales by Region (K Units), 2027–2032
 Table 22. Global Hemoperfusion Sales Market Share by Region (2027–2032)
 Table 23. Global Hemoperfusion Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Hemoperfusion Revenue Market Share by Region (2021–2026)
 Table 25. Global Hemoperfusion Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Hemoperfusion Revenue Market Share by Region (2027–2032)
 Table 27. North America Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Hemoperfusion Sales by Country (K Units), 2021–2026
 Table 29. North America Hemoperfusion Sales by Country (K Units), 2027–2032
 Table 30. North America Hemoperfusion Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Hemoperfusion Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Hemoperfusion Sales by Country (K Units), 2021–2026
 Table 34. Europe Hemoperfusion Sales by Country (K Units), 2027–2032
 Table 35. Europe Hemoperfusion Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Hemoperfusion Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Hemoperfusion Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Hemoperfusion Sales by Region (K Units), 2021–2026
 Table 39. Asia Pacific Hemoperfusion Sales by Region (K Units), 2027–2032
 Table 40. Asia Pacific Hemoperfusion Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Hemoperfusion Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Hemoperfusion Sales by Country (K Units), 2021–2026
 Table 44. Latin America Hemoperfusion Sales by Country (K Units), 2027–2032
 Table 45. Latin America Hemoperfusion Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Hemoperfusion Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Hemoperfusion Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Hemoperfusion Sales by Country (K Units), 2021–2026
 Table 49. Middle East and Africa Hemoperfusion Sales by Country (K Units), 2027–2032
 Table 50. Middle East and Africa Hemoperfusion Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Hemoperfusion Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Hemoperfusion Sales (K Units) by Type (2021–2026)
 Table 53. Global Hemoperfusion Sales (K Units) by Type (2027–2032)
 Table 54. Global Hemoperfusion Sales Market Share by Type (2021–2026)
 Table 55. Global Hemoperfusion Sales Market Share by Type (2027–2032)
 Table 56. Global Hemoperfusion Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Hemoperfusion Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Hemoperfusion Revenue Market Share by Type (2021–2026)
 Table 59. Global Hemoperfusion Revenue Market Share by Type (2027–2032)
 Table 60. Global Hemoperfusion Price (USD/Unit) by Type (2021–2026)
 Table 61. Global Hemoperfusion Price (USD/Unit) by Type (2027–2032)
 Table 62. Global Hemoperfusion Sales (K Units) by Application (2021–2026)
 Table 63. Global Hemoperfusion Sales (K Units) by Application (2027–2032)
 Table 64. Global Hemoperfusion Sales Market Share by Application (2021–2026)
 Table 65. Global Hemoperfusion Sales Market Share by Application (2027–2032)
 Table 66. Global Hemoperfusion Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Hemoperfusion Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Hemoperfusion Revenue Market Share by Application (2021–2026)
 Table 69. Global Hemoperfusion Revenue Market Share by Application (2027–2032)
 Table 70. Global Hemoperfusion Price (USD/Unit) by Application (2021–2026)
 Table 71. Global Hemoperfusion Price (USD/Unit) by Application (2027–2032)
 Table 72. Jianfan Biotech Company Information
 Table 73. Jianfan Biotech Description and Business Overview
 Table 74. Jianfan Biotech Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 75. Jianfan Biotech Hemoperfusion Product
 Table 76. Jianfan Biotech Recent Developments/Updates
 Table 77. Kangbei Medical Company Information
 Table 78. Kangbei Medical Description and Business Overview
 Table 79. Kangbei Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 80. Kangbei Medical Hemoperfusion Product
 Table 81. Kangbei Medical Recent Developments/Updates
 Table 82. Foshan Boxin (Lily Medical) Company Information
 Table 83. Foshan Boxin (Lily Medical) Description and Business Overview
 Table 84. Foshan Boxin (Lily Medical) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 85. Foshan Boxin (Lily Medical) Hemoperfusion Product
 Table 86. Foshan Boxin (Lily Medical) Recent Developments/Updates
 Table 87. Baxter Company Information
 Table 88. Baxter Description and Business Overview
 Table 89. Baxter Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 90. Baxter Hemoperfusion Product
 Table 91. Baxter Recent Developments/Updates
 Table 92. Asahi Kasei Company Information
 Table 93. Asahi Kasei Description and Business Overview
 Table 94. Asahi Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 95. Asahi Kasei Hemoperfusion Product
 Table 96. Asahi Kasei Recent Developments/Updates
 Table 97. Key Raw Materials Lists
 Table 98. Raw Materials Key Suppliers Lists
 Table 99. Hemoperfusion Distributors List
 Table 100. Hemoperfusion Customers List
 Table 101. Hemoperfusion Market Trends
 Table 102. Hemoperfusion Market Drivers
 Table 103. Hemoperfusion Market Challenges
 Table 104. Hemoperfusion Market Restraints
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemoperfusion
 Figure 2. Global Hemoperfusion Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hemoperfusion Market Share by Type: 2025 & 2032
 Figure 4. Activated Carbon Adsorption Product Picture
 Figure 5. Resin Adsorption Product Picture
 Figure 6. Global Hemoperfusion Market Value by Feature (US$ Million), 2021–2032
 Figure 7. Global Hemoperfusion Market Share by Feature: 2025 vs 2032
 Figure 8. Plasma Perfusion Product Picture
 Figure 9. Whole Blood Perfusion Product Picture
 Figure 10. Global Hemoperfusion Market Value by Channel (US$ Million), 2021–2032
 Figure 11. Global Hemoperfusion Market Share by Channel: 2025 vs 2032
 Figure 12. Direct Selling Product Picture
 Figure 13. Distribution Product Picture
 Figure 14. Global Hemoperfusion Market Value by Application (US$ Million), 2021–2032
 Figure 15. Global Hemoperfusion Market Share by Application: 2025 & 2032
 Figure 16. Hepatic Encephalopathy
 Figure 17. Certain Autoimmune Diseases
 Figure 18. Drug Overdose
 Figure 19. Specific Intoxications
 Figure 20. Others
 Figure 21. Global Hemoperfusion Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 22. Global Hemoperfusion Market Size (US$ Million), 2021–2032
 Figure 23. Global Hemoperfusion Sales (K Units), 2021–2032
 Figure 24. Global Hemoperfusion Average Price (USD/Unit), 2021–2032
 Figure 25. Hemoperfusion Report Years Considered
 Figure 26. Hemoperfusion Sales Share by Manufacturers in 2025
 Figure 27. Global Hemoperfusion Revenue Share by Manufacturers in 2025
 Figure 28. Top 5 and Top 10 Global Hemoperfusion Players: Market Share by Revenue in Hemoperfusion in 2025
 Figure 29. Hemoperfusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 30. Global Hemoperfusion Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 31. North America Hemoperfusion Sales Market Share by Country (2021–2032)
 Figure 32. North America Hemoperfusion Revenue Market Share by Country (2021–2032)
 Figure 33. U.S. Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Canada Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Europe Hemoperfusion Sales Market Share by Country (2021–2032)
 Figure 36. Europe Hemoperfusion Revenue Market Share by Country (2021–2032)
 Figure 37. Germany Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. France Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. U.K. Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Italy Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Russia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Asia Pacific Hemoperfusion Sales Market Share by Region (2021–2032)
 Figure 43. Asia Pacific Hemoperfusion Revenue Market Share by Region (2021–2032)
 Figure 44. China Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Japan Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. South Korea Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. India Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Australia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. China Taiwan Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Indonesia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Thailand Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Malaysia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Latin America Hemoperfusion Sales Market Share by Country (2021–2032)
 Figure 54. Latin America Hemoperfusion Revenue Market Share by Country (2021–2032)
 Figure 55. Mexico Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Brazil Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Argentina Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Middle East and Africa Hemoperfusion Sales Market Share by Country (2021–2032)
 Figure 59. Middle East and Africa Hemoperfusion Revenue Market Share by Country (2021–2032)
 Figure 60. Turkey Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Saudi Arabia Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. UAE Hemoperfusion Revenue Growth Rate (US$ Million), 2021–2032
 Figure 63. Global Sales Market Share of Hemoperfusion by Type (2021–2032)
 Figure 64. Global Revenue Market Share of Hemoperfusion by Type (2021–2032)
 Figure 65. Global Hemoperfusion Price (USD/Unit) by Type (2021–2032)
 Figure 66. Global Sales Market Share of Hemoperfusion by Application (2021–2032)
 Figure 67. Global Revenue Market Share of Hemoperfusion by Application (2021–2032)
 Figure 68. Global Hemoperfusion Price (USD/Unit) by Application (2021–2032)
 Figure 69. Hemoperfusion Value Chain
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS